MCID: LYS030
MIFTS: 25

Lysosomal Storage Disease with Skeletal Involvement

Categories: Bone diseases, Rare diseases

Aliases & Classifications for Lysosomal Storage Disease with Skeletal Involvement

MalaCards integrated aliases for Lysosomal Storage Disease with Skeletal Involvement:

Name: Lysosomal Storage Disease with Skeletal Involvement 58
Dysostosis Multiplex 58

Classifications:

Orphanet: 58  
Rare bone diseases


External Ids:

Orphanet 58 ORPHA93448

Summaries for Lysosomal Storage Disease with Skeletal Involvement

MalaCards based summary : Lysosomal Storage Disease with Skeletal Involvement, also known as dysostosis multiplex, is related to hurler syndrome and scheie syndrome. An important gene associated with Lysosomal Storage Disease with Skeletal Involvement is IDUA (Alpha-L-Iduronidase). Affiliated tissues include bone, bone marrow and skin.

Related Diseases for Lysosomal Storage Disease with Skeletal Involvement

Diseases related to Lysosomal Storage Disease with Skeletal Involvement via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 23)
# Related Disease Score Top Affiliating Genes
1 hurler syndrome 12.4
2 scheie syndrome 11.8
3 mucopolysaccharidosis-plus syndrome 11.8
4 mucopolysaccharidosis, type vi 11.7
5 mucolipidosis ii alpha/beta 11.6
6 mucopolysaccharidosis, type vii 11.6
7 fucosidosis 11.6
8 mucopolysaccharidosis, type ii 11.6
9 mucolipidosis iii gamma 11.5
10 galactosialidosis 11.5
11 glycoproteinosis 11.5
12 mannosidosis, alpha b, lysosomal 11.3
13 mucolipidosis iii alpha/beta 11.3
14 neuraminidase deficiency 11.3
15 multiple sulfatase deficiency 11.3
16 hurler-scheie syndrome 11.3
17 mucopolysaccharidosis iii 11.3
18 mucopolysaccharidosis iv 11.3
19 dysostosis 10.6
20 marfan syndrome 9.9
21 gm1-gangliosidosis, type i 9.9
22 mucolipidosis 9.9
23 blood protein disease 9.9

Graphical network of the top 20 diseases related to Lysosomal Storage Disease with Skeletal Involvement:



Diseases related to Lysosomal Storage Disease with Skeletal Involvement

Symptoms & Phenotypes for Lysosomal Storage Disease with Skeletal Involvement

Drugs & Therapeutics for Lysosomal Storage Disease with Skeletal Involvement

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 A Multicenter, Multinational Study That Will Evaluate Clinical and Surrogate Parameters Known to be Affected in Alpha-Mannosidosis Patients Completed NCT00498420
2 Biomarker for Hurler Disease - An International, Multicenter, Epidemiological Protocol Recruiting NCT02298712
3 Biomarker for Mucolipidosis Disorder Type I, II, III, IV AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL Recruiting NCT02298673
4 Biomarker for Gangliosidosis: BioGM1 / BioGM2 AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL Recruiting NCT02298647

Search NIH Clinical Center for Lysosomal Storage Disease with Skeletal Involvement

Genetic Tests for Lysosomal Storage Disease with Skeletal Involvement

Anatomical Context for Lysosomal Storage Disease with Skeletal Involvement

MalaCards organs/tissues related to Lysosomal Storage Disease with Skeletal Involvement:

40
Bone, Bone Marrow, Skin, Eye, Brain, Liver, Testes

Publications for Lysosomal Storage Disease with Skeletal Involvement

Articles related to Lysosomal Storage Disease with Skeletal Involvement:

(show top 50) (show all 202)
# Title Authors PMID Year
1
A Novel Homozygous Mutation in the FUCA1 Gene Highlighting Fucosidosis as a Cause of Dystonia: Case Report and Literature Review. 61
31064022 2019
2
Identification of arylsulfatase B gene mutations and clinical presentations of Iranian patients with Mucopolysaccharidosis VI. 61
31009684 2019
3
Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: Divergent clinical outcomes in two Japanese siblings. 61
30755342 2019
4
Growth impairment and limited range of joint motion in children should raise suspicion of an attenuated form of mucopolysaccharidosis: expert opinion. 61
30740618 2019
5
Oral manifestations in patients and dogs with mucopolysaccharidosis Type VII. 61
30653816 2019
6
Treatment of thoracolumbar kyphosis in patients with mucopolysaccharidosis type I: results of an international consensus procedure. 61
30658664 2019
7
Orthopaedic challenges for mucopolysaccharidoses. 61
30442173 2018
8
Mucopolysaccharidoses: overview of neuroimaging manifestations. 61
29752520 2018
9
Morquio B patient/caregiver survey: First insight into the natural course of a rare GLB1 related condition. 61
30094186 2018
10
Genetic Testing of a Large Consanguineous Pakistani Family Affected with Mucolipidosis III Gamma Through Next-Generation Sequencing. 61
30235039 2018
11
Mucolipidosis type III, a series of adult patients. 61
29704188 2018
12
Biochemical and molecular analyses of infantile sialic acid storage disease in a patient with nonimmune hydrops fetalis. 61
29654786 2018
13
Type 1 sialidosis presenting with ataxia, seizures and myoclonus with no visual involvement. 61
30023283 2018
14
Clinical features of Mexican patients with Mucopolysaccharidosis type I. 61
28973713 2017
15
Early hematopoietic stem cell transplantation in a patient with severe mucopolysaccharidosis II: A 7 years follow-up. 61
28649514 2017
16
The effect of galsulfase enzyme replacement therapy on the growth of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). 61
28457718 2017
17
Mucopolysaccharidoses - Clinical Spectrum and Frequency of Different Types. 61
28292383 2017
18
I Cell Disease (Mucolipidosis II Alpha/Beta): From Screening to Molecular Diagnosis. 61
27785713 2017
19
A probable new syndrome with the storage disease phenotype caused by the VPS33A gene mutation. 61
27547915 2017
20
Early characteristic radiographic changes in mucolipidosis II. 61
27525427 2016
21
Sialidoses. 61
27621198 2016
22
Neuroimaging Findings in Patients with Mucopolysaccharidosis: What You Really Need to Know. 61
27618324 2016
23
Clinical and laboratory outcomes after umbilical cord blood transplantation in a patient with mucolipidosis II alpha/beta. 61
26789537 2016
24
MRI and MRS findings in fucosidosis; a rare lysosomal storage disease. 61
26515723 2016
25
Progression of Hip Dysplasia in Mucopolysaccharidosis Type I Hurler After Successful Hematopoietic Stem Cell Transplantation. 61
26935461 2016
26
Musculoskeletal/Radiological Manifestations of Mucolipidosis II (I-Cell disease) in late Adolescence/Early Adulthood. 61
29073299 2016
27
Clinical Evolution After Enzyme Replacement Therapy in Twins with the Severe Form of Maroteaux-Lamy Syndrome. 61
26920906 2016
28
Clinical and neuroradiological approach to fucosidosis in a child with atypical presentation. 61
26713028 2015
29
Identifying the need for a multidisciplinary approach for early recognition of mucopolysaccharidosis VI (MPS VI). 61
25892708 2015
30
Hunter syndrome with late age of presentation: clinical description of a case and review of the literature. 61
25976201 2015
31
The clinical spectrum and pathophysiology of skeletal complications in lysosomal storage disorders. 61
25987175 2015
32
Airway-related symptoms and surgeries in patients with mucopolysaccharidosis I. 61
25214650 2015
33
Spinal involvement in mucopolysaccharidoses: a review. 61
25358811 2015
34
Clinical Findings and Natural History in Ten Unrelated Families with Juvenile and Adult GM1 Gangliosidosis. 61
26108645 2015
35
Diagnosing lysosomal storage disorders: mucopolysaccharidosis type I. 61
25599668 2015
36
Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis I. 61
25359774 2014
37
Mucopolysaccharidosis type I. 61
25345091 2014
38
Eight years experience from a skeletal dysplasia referral center in a tertiary hospital in Southern India: a model for the diagnosis and treatment of rare diseases in a developing country. 61
25044831 2014
39
Whole-exome sequencing expands the phenotype of Hunter syndrome. 61
23844659 2014
40
Molecular evaluation of a novel missense mutation & an insertional truncating mutation in SUMF1 gene. 61
25222778 2014
41
Late diagnosis of fucosidosis in a child with progressive fixed dystonia, bilateral pallidal lesions and red spots on the skin. 61
24636010 2014
42
A case of fucosidosis type II: diagnosed with dysmorphological and radiological findings. 61
25818965 2014
43
[Analysis of clinical features and arylsulfatase B gene mutation in thirteen Chinese children with mucopolysaccharidosis type VI]. 61
25190157 2014
44
Siblings with fucosidosis. 61
25250075 2014
45
Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) in the pre-Columbian culture of Colombia. 61
25100895 2014
46
Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux-Lamy syndrome): under-recognized and challenging to diagnose. 61
24389823 2014
47
Hunter syndrome (Mucopolysaccharidosis type II), severe phenotype: long term follow-up on patients undergone to hematopoietic stem cell transplantation. 61
24056375 2013
48
Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA. 61
23665161 2013
49
A novel mutation in a large family causes a unique phenotype of Mucolipidosis IV. 61
23685283 2013
50
Mucopolysaccharidosis type II with inguinal hernia. 61
24908534 2013

Variations for Lysosomal Storage Disease with Skeletal Involvement

ClinVar genetic disease variations for Lysosomal Storage Disease with Skeletal Involvement:

6 (show top 50) (show all 161) ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 IDUA NM_000203.5(IDUA):c.235G>A (p.Ala79Thr)SNV Benign/Likely benign, other 195038 rs58037052 4:981673-981673 4:987885-987885
2 IDUA NM_000203.5(IDUA):c.965T>A (p.Val322Glu)SNV Likely benign, other 222992 rs76722191 4:995942-995942 4:1002154-1002154
3 IDUA NM_000203.5(IDUA):c.246C>G (p.His82Gln)SNV Benign/Likely benign, other 92637 rs148775298 4:981684-981684 4:987896-987896
4 IDUA NM_000203.5(IDUA):c.152G>A (p.Gly51Asp)SNV Pathogenic 193061 rs794726877 4:981024-981024 4:987236-987236
5 IDUA NM_000203.5(IDUA):c.1874A>G (p.Tyr625Cys)SNV Pathogenic 100723 rs587779401 4:998093-998093 4:1004305-1004305
6 IDUA NM_000203.5(IDUA):c.1402+2T>GSNV Pathogenic 553131 rs1553917428 4:996734-996734 4:1002946-1002946
7 IDUA NM_000203.5(IDUA):c.1728-1G>CSNV Pathogenic 556064 rs1249951282 4:997799-997799 4:1004011-1004011
8 IDUA NM_000203.5(IDUA):c.1210G>T (p.Glu404Ter)SNV Pathogenic 552095 rs1340421020 4:996540-996540 4:1002752-1002752
9 IDUA NM_000203.5(IDUA):c.1139A>G (p.Gln380Arg)SNV Pathogenic 550799 rs762903007 4:996223-996223 4:1002435-1002435
10 IDUA NM_000203.5(IDUA):c.606C>A (p.Tyr202Ter)SNV Pathogenic 552333 rs1033313360 4:995483-995483 4:1001695-1001695
11 IDUA NM_000203.5(IDUA):c.385+1G>CSNV Pathogenic 551966 rs780615798 4:994486-994486 4:1000698-1000698
12 IDUA NM_000203.5(IDUA):c.494-1G>ASNV Pathogenic 557942 rs794727701 4:995255-995255 4:1001467-1001467
13 IDUA NM_000203.5(IDUA):c.1898C>T (p.Ser633Leu)SNV Pathogenic 556406 rs886043347 4:998117-998117 4:1004329-1004329
14 IDUA NM_000203.5(IDUA):c.1854C>A (p.Tyr618Ter)SNV Pathogenic 554826 rs746936485 4:998073-998073 4:1004285-1004285
15 IDUA NM_000203.5(IDUA):c.223G>A (p.Ala75Thr)SNV Pathogenic 222993 rs758452450 4:981661-981661 4:987873-987873
16 IDUA NM_000203.5(IDUA):c.386-2A>GSNV Pathogenic 222994 rs777295041 4:994668-994668 4:1000880-1000880
17 IDUA NM_000203.5(IDUA):c.590-7G>ASNV Pathogenic 222996 rs762411583 4:995460-995460 4:1001672-1001672
18 IDUA NM_000203.5(IDUA):c.653T>C (p.Leu218Pro)SNV Pathogenic 222995 rs869025584 4:995530-995530 4:1001742-1001742
19 IDUA NM_000203.5(IDUA):c.612_615dup (p.Ser206fs)duplication Pathogenic 226413 rs875989947 4:995489-995492 4:1001701-1001704
20 IDUA NM_000203.5(IDUA):c.1855C>T (p.Arg619Ter)SNV Pathogenic 280976 rs121965031 4:998074-998074 4:1004286-1004286
21 IDUA NM_000203.5(IDUA):c.1037T>G (p.Leu346Arg)SNV Pathogenic 11927 rs121965033 4:996121-996121 4:1002333-1002333
22 IDUA NM_000203.5(IDUA):c.1614del (p.His539fs)deletion Pathogenic 167191 rs727503967 4:997222-997222 4:1003434-1003434
23 IDUA IDUA, 1-BP DEL, 1702Gdeletion Pathogenic 11912
24 IDUA NM_000203.5(IDUA):c.192C>A (p.Tyr64Ter)SNV Pathogenic 11914 rs121965022 4:981630-981630 4:987842-987842
25 IDUA NM_000203.5(IDUA):c.928C>T (p.Gln310Ter)SNV Pathogenic 11915 rs121965023 4:995905-995905 4:1002117-1002117
26 IDUA NM_000203.5(IDUA):c.1096A>C (p.Thr366Pro)SNV Pathogenic 11916 rs121965024 4:996180-996180 4:1002392-1002392
27 IDUA NM_000203.5(IDUA):c.1861C>T (p.Arg621Ter)SNV Pathogenic 11917 rs121965025 4:998080-998080 4:1004292-1004292
28 IDUA NM_000203.5(IDUA):c.1469T>C (p.Leu490Pro)SNV Pathogenic 11919 rs121965027 4:996890-996890 4:1003102-1003102
29 IDUA NM_000203.5(IDUA):c.613_617dup (p.Glu207fs)duplication Pathogenic 11921 rs786200915 4:995490-995494 4:1001702-1001706
30 IDUA NM_000203.5(IDUA):c.266G>A (p.Arg89Gln)SNV Pathogenic 11922 rs121965029 4:981704-981704 4:987916-987916
31 IDUA NM_000203.5(IDUA):c.1205G>A (p.Trp402Ter)SNV Pathogenic 11908 rs121965019 4:996535-996535 4:1002747-1002747
32 IDUA NM_000203.5(IDUA):c.208C>T (p.Gln70Ter)SNV Pathogenic 11909 rs121965020 4:981646-981646 4:987858-987858
33 IDUA NM_000203.5(IDUA):c.1598C>G (p.Pro533Arg)SNV Pathogenic 11910 rs121965021 4:997206-997206 4:1003418-1003418
34 IDUA NM_000203.5(IDUA):c.1206G>A (p.Trp402Ter)SNV Pathogenic 555230 rs991612107 4:996536-996536 4:1002748-1002748
35 IDUA NM_000203.5(IDUA):c.1882C>T (p.Arg628Ter)SNV Pathogenic 550421 rs756572099 4:998101-998101 4:1004313-1004313
36 IDUA NM_000203.5(IDUA):c.1743C>G (p.Tyr581Ter)SNV Pathogenic 550883 rs776787370 4:997815-997815 4:1004027-1004027
37 IDUA NM_000203.5(IDUA):c.1A>C (p.Met1Leu)SNV Pathogenic 550458 rs1553914737 4:980873-980873 4:987085-987085
38 IDUA NM_000203.5(IDUA):c.979G>C (p.Ala327Pro)SNV Pathogenic/Likely pathogenic 167190 rs199801029 4:996063-996063 4:1002275-1002275
39 IDUA NM_000203.5(IDUA):c.191_192del (p.Tyr64fs)deletion Pathogenic/Likely pathogenic 195040 rs794727240 4:981629-981630 4:987841-987842
40 IDUA NM_000203.5(IDUA):c.1044C>G (p.Asn348Lys)SNV Pathogenic/Likely pathogenic 557870 rs746766617 4:996128-996128 4:1002340-1002340
41 IDUA NM_000203.5(IDUA):c.878_889dup (p.Thr293_Tyr296dup)duplication Pathogenic/Likely pathogenic 550382 rs779762183 4:995851-995851 4:1002067-1002078
42 IDUA NM_000203.5(IDUA):c.299+1G>TSNV Pathogenic/Likely pathogenic 92639 rs398123259 4:981738-981738 4:987950-987950
43 IDUA NM_000203.5(IDUA):c.1487C>G (p.Pro496Arg)SNV Pathogenic/Likely pathogenic 496861 rs772416503 4:996908-996908 4:1003120-1003120
44 IDUA NM_000203.5(IDUA):c.713T>A (p.Leu238Gln)SNV Pathogenic/Likely pathogenic 265418 rs148789453 4:995590-995590 4:1001802-1001802
45 IDUA NM_000203.5(IDUA):c.53T>C (p.Leu18Pro)SNV Pathogenic/Likely pathogenic 193062 rs794726878 4:980925-980925 4:987137-987137
46 IDUA NM_000203.5(IDUA):c.1650+5G>ASNV Pathogenic/Likely pathogenic 92634 rs398123256 4:997263-997263 4:1003475-1003475
47 IDUA NM_000203.5(IDUA):c.159-1G>ASNV Likely pathogenic 556690 rs1553914935 4:981596-981596 4:987808-987808
48 IDUA NM_000203.5(IDUA):c.1029C>G (p.Tyr343Ter)SNV Likely pathogenic 550474 rs764196171 4:996113-996113 4:1002325-1002325
49 IDUA NM_000203.5(IDUA):c.1045_1047del (p.Asp349del)deletion Likely pathogenic 557885 rs1230096882 4:996126-996129 4:1002341-1002343
50 IDUA NM_000203.5(IDUA):c.536C>G (p.Thr179Arg)SNV Likely pathogenic 556358 rs776098539 4:995298-995298 4:1001510-1001510

Expression for Lysosomal Storage Disease with Skeletal Involvement

Search GEO for disease gene expression data for Lysosomal Storage Disease with Skeletal Involvement.

Pathways for Lysosomal Storage Disease with Skeletal Involvement

GO Terms for Lysosomal Storage Disease with Skeletal Involvement

Sources for Lysosomal Storage Disease with Skeletal Involvement

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....